Here is a comprehensive, exam-level reference on allergens for allergology study.
Allergens — Complete Reference for Allergology
1. Definition
An allergen is an antigen (almost always a protein or glycoprotein) capable of inducing an IgE-mediated (Type I hypersensitivity) immune response in a genetically susceptible (atopic) individual. Most are harmless environmental proteins that the immune system misidentifies as threats.
2. Properties of an Allergen
For a substance to act as an allergen, it typically possesses:
| Property | Details |
|---|
| Protein/glycoprotein nature | Nearly all allergens are proteins (MW 5–70 kDa); carbohydrates alone rarely sensitize |
| Low molecular weight | Optimally 10–70 kDa — small enough to penetrate mucosa, large enough for cross-linking IgE |
| Water solubility | Facilitates diffusion across mucosal surfaces |
| Enzymatic activity | Many allergens are proteases (e.g., Der p 1 from dust mite) that disrupt epithelial tight junctions |
| Low dose exposure | Sensitization occurs at trace quantities |
| Stability | Must survive environmental conditions to reach sensitizing surfaces |
| Carrier effect | Can bind to particles (pollen, dust) for airborne transport |
3. Nomenclature of Allergens
The WHO/IUIS (International Union of Immunological Societies) Allergen Nomenclature uses a standardized system:
Format: First 3 letters of genus + first letter of species + Arabic number
| Example | Source |
|---|
| Der p 1 | Dermatophagoides pteronyssinus allergen 1 (house dust mite) |
| Fel d 1 | Felis domesticus allergen 1 (cat) |
| Bet v 1 | Betula verrucosa allergen 1 (birch pollen) |
| Ara h 1 | Arachis hypogaea allergen 1 (peanut) |
| Alt a 1 | Alternaria alternata allergen 1 (mold) |
4. Classification of Allergens
4.1 By Route of Exposure
| Route | Examples |
|---|
| Inhaled (aeroallergens) | Pollen, dust mite, mold spores, pet dander, cockroach |
| Ingested (food allergens) | Peanut, tree nuts, milk, egg, wheat, soy, fish, shellfish |
| Contact (cutaneous) | Nickel, latex, fragrances, cosmetics (Type IV mostly) |
| Injected (parenteral) | Venom (bee, wasp), drugs (penicillin), blood products |
| Occupational | Latex (healthcare), flour (bakers), isocyanates, animal proteins |
4.2 By Source
A. Aeroallergens
1. Pollen
- Major cause of allergic rhinitis and asthma
- Seasonal (pollinosis/hay fever)
- Categories:
- Tree pollen (spring): Birch (Betula), Oak, Olive, Plane — Bet v 1 is the most studied
- Grass pollen (late spring/summer): Timothy grass (Phleum pratense — Phl p 1, 5), Bermuda grass, Ryegrass
- Weed pollen (late summer/autumn): Ragweed (Ambrosia — Amb a 1), Mugwort (Artemisia — Art v 1), Parietaria
- Characteristics: 10–100 μm in size; released in dry, windy conditions; peak morning hours
- Paucimicronic particles (sub-pollen particles <5 μm) can reach the lower airway
2. House Dust Mite (HDM)
- Most important perennial indoor allergen worldwide
- Species: Dermatophagoides pteronyssinus (Europe), D. farinae (North America), Blomia tropicalis (tropical)
- Source of allergen: fecal particles and body fragments
- Key allergens:
- Der p 1 (group 1): cysteine protease — disrupts epithelial barrier, cleaves CD23 on B cells
- Der p 2 (group 2): MD-2-like protein, signals via TLR4 pathway
- Der p 23: peritrophic membrane protein, potent sensitizer
- Thrives in mattresses, carpets, upholstered furniture
- Optimal conditions: temperature 20–25°C, humidity >55%
3. Animal Allergens
- Cat (Felis domesticus): Fel d 1 (uroglobin secretoglobin) — secreted by sebaceous and salivary glands; airborne, sticky, persists for months; 20 μg/g in settled dust
- Dog (Canis familiaris): Can f 1 (lipocalin), Can f 5 (kallikrein — male-specific)
- Rodents (mice, rats): Mus m 1 (urinary protein); major occupational allergen in lab workers
- Cockroach: Bla g 1, Bla g 2 (aspartate protease) — major urban allergen, linked to inner-city asthma
- Horse, cow, pig: Occupational importance
4. Mold (Fungal) Allergens
- Outdoor: Alternaria alternata (Alt a 1), Cladosporium herbarum (Cla h 1) — peak in warm months; strongly linked to severe asthma
- Indoor: Aspergillus fumigatus (Asp f allergens), Penicillium, Trichosporon
- Spore sizes: 2–20 μm — reach lower airways
- Allergic bronchopulmonary aspergillosis (ABPA): Th2-mediated response to Aspergillus antigens
B. Food Allergens
Big 9 (USA FDA — 2023): Milk, Egg, Peanut, Tree nuts, Fish, Shellfish, Wheat, Soy, Sesame
| Allergen | Key Protein | Notes |
|---|
| Cow's milk | Casein, β-lactoglobulin, α-lactalbumin | Most common in infants; β-lactoglobulin absent in human milk |
| Egg | Ovomucoid (Gal d 1), Ovalbumin (Gal d 2) | Ovomucoid is heat-stable → no tolerance on cooking |
| Peanut | Ara h 1 (vicilin), Ara h 2 (2S albumin), Ara h 3 (legumin), Ara h 8 (PR-10) | Ara h 2 most predictive of severe reactions; usually lifelong |
| Tree nuts | Cor a (hazelnut), Jug r (walnut), Ana o (cashew) | Cross-reactive with pollen (Bet v 1 homologs) |
| Fish | Gad c 1 (parvalbumin) — Gadus callarias | Heat-stable; cross-reactive across species |
| Shellfish | Pen a 1 (tropomyosin) — shrimp | Cross-reactive with house dust mite (tropomyosin) |
| Wheat | Tri a 19 (ω-5 gliadin), Tri a 14 (nsLTP) | ω-5 gliadin → wheat-dependent exercise-induced anaphylaxis (WDEIA) |
| Soy | Gly m 4 (PR-10 — Bet v 1 homolog), Gly m 5 (β-conglycinin) | Gly m 4 → birch pollen–soy OAS |
| Sesame | Ses i 1 (2S albumin) | Increasing prevalence; listed as 9th major allergen |
C. Venom Allergens (Hymenoptera)
| Insect | Key Allergens |
|---|
| Honey bee (Apis mellifera) | Api m 1 (phospholipase A2), Api m 2 (hyaluronidase), Api m 10 (icarapin) |
| Vespid wasps (Vespula) | Ves v 1 (phospholipase A1), Ves v 5 (antigen 5) |
| Yellow jacket | Same as Vespula — Ves v 5 most diagnostically important |
| Bumblebee | Bomb p 1, Bomb p 4 — important in greenhouse workers |
| Fire ant | Sol i 1–4 |
Cross-reactive carbohydrate determinants (CCDs) cause IgE cross-reactivity between bee and wasp venoms in ~50% of cases — component-resolved diagnostics (CRD) is essential.
D. Drug Allergens
| Drug | Mechanism | Key Allergen/Hapten |
|---|
| Penicillin | Hapten — penicilloyl group (major determinant) binds serum proteins | Pen G, Pen V; cross-reactivity with cephalosporins (~2%) |
| Cephalosporins | Similar β-lactam ring haptenation | R1 side chain determines cross-reactivity |
| NSAIDs | Pharmacological (COX-1 inhibition, not IgE) — most cases | Aspirin, ibuprofen → leukotriene overflow |
| Muscle relaxants | IgE-mediated; quaternary ammonium groups | Rocuronium, succinylcholine |
| Radiocontrast media | Non-IgE (direct mast cell activation) | Iodinated contrast |
| Biologics | Anti-drug antibodies (IgE or IgG4) | Cetuximab (anti-Gal-α-1,3-Gal — cross-reactive with tick bite α-gal syndrome) |
E. Occupational Allergens
| Occupation | Allergen |
|---|
| Bakers/millers | Wheat flour (Tri a 14, Tri a 19), α-amylase (Aspergillus) |
| Healthcare workers | Latex (Hev b 1–13), psyllium, glutaraldehyde |
| Lab animal workers | Mouse urinary proteins (Mus m 1), rat (Rat n 1) |
| Hairdressers | Persulfate compounds, PPD (para-phenylenediamine — Type IV) |
| Painters/spray workers | Isocyanates (MDI, TDI) — highly potent respiratory sensitizers |
| Farmers | Storage mites (Lepidoglyphus destructor — Lep d 1), grain dust, animal dander |
5. Molecular Classification — Allergen Superfamilies/Protein Families
| Protein Family | Allergen Examples | Properties |
|---|
| Prolamin superfamily (2S albumins, nsLTPs, prolamins) | Ara h 2, Tri a 14, Pru p 3 | Heat/digestion stable → systemic reactions |
| Cupin superfamily (vicilins, legumins) | Ara h 1, Ara h 3 | Stable storage proteins |
| PR-10 proteins (Bet v 1 homologs) | Bet v 1, Mal d 1, Gly m 4, Ara h 8 | Heat/digestion labile → oral allergy syndrome |
| Profilins | Bet v 2, Phl p 12, Act d 9 | Pan-allergens; cause extensive pollen-food cross-reactivity |
| Tropomyosins | Pen a 1 (shrimp), Der p 10 (dust mite) | Cross-reactivity shrimp↔mite |
| Lipocalins | Fel d 4 (cat), Can f 1/2/6 (dog), Mus m 1 | Bind small hydrophobic ligands |
| Serum albumins | Bos d 6 (cow), Can f 3 (dog) | Cross-react across mammals (pork-cat syndrome) |
| Parvalbumins | Gad c 1 (fish) | Heat-stable; cause fish cross-reactivity |
| Tropomyosin | Pen a 1 | Pan-allergen for crustaceans/insects |
| Defensin-like | Hev b 5 (latex) | |
6. Cross-Reactivity & Pollen-Food Allergy Syndrome (PFAS)
Cross-reactivity occurs when IgE antibodies raised against one allergen recognize structurally homologous proteins in another source.
Major Cross-Reactive Syndromes
| Syndrome | Primary Sensitizer | Cross-Reactive Foods |
|---|
| Birch-fruit syndrome (PFAS) | Birch pollen (Bet v 1) | Apple (Mal d 1), pear, peach, cherry, hazelnut, carrot, celery, soy |
| Grass-cereal syndrome | Grass pollen | Wheat, corn |
| Mugwort-celery-spice | Mugwort (Art v 1, Art v 3) | Celery, carrot, fennel, coriander, mustard |
| Latex-fruit syndrome | Latex (Hev b 5, 6, 8) | Banana, avocado, kiwi, chestnut, papaya |
| Shrimp-mite syndrome | HDM tropomyosin (Der p 10) | Shrimp, crab, lobster |
| α-Gal syndrome | Tick bite (Amblyomma americanum) sensitization | Red meat (beef, pork, lamb) — delayed reaction 3–6 h |
| Pork-cat syndrome | Cat serum albumin (Fel d 2) | Pork, beef (serum albumins cross-react) |
| Fish-bird syndrome | Bird serum albumin | Fish (parvalbumin cross-reactivity less clear — misnomer) |
7. Sensitization vs. Allergy
| Term | Definition |
|---|
| Sensitization | Presence of specific IgE to an allergen (detected by SPT or serology) WITHOUT clinical symptoms |
| Allergy | Sensitization + clinical symptoms upon re-exposure |
| Atopy | Genetic predisposition to produce IgE against environmental allergens |
| Monosensitization | IgE to a single allergen source |
| Polysensitization | IgE to multiple unrelated allergen sources |
8. Mechanism of Sensitization (Immunological Pathway)
1. Allergen exposure → penetrates epithelial barrier (aided by protease activity of some allergens)
2. Epithelium releases alarmins: TSLP, IL-25 (IL-17E), IL-33
3. Alarmins activate Group 2 Innate Lymphoid Cells (ILC2s) → IL-4, IL-5, IL-13
4. Antigen presentation by dendritic cells → naïve T cells polarize to Th2
5. Th2 cytokines:
- IL-4 → B cell class switching to IgE
- IL-5 → eosinophil differentiation and survival
- IL-13 → mucus hypersecretion, smooth muscle effects
6. Plasma cells secrete allergen-specific IgE into circulation
7. IgE binds high-affinity FcεRI receptors on mast cells and basophils → SENSITIZED STATE
8. Re-exposure: Allergen cross-links IgE on mast cells → degranulation → mediator release
Mediators released on activation:
- Preformed (immediate): Histamine, tryptase, heparin, chymase
- Newly synthesized: Prostaglandin D2 (PGD2), leukotriene C4/D4/E4, PAF
- Cytokines (late phase): TNF-α, IL-4, IL-5, IL-13
9. Component-Resolved Diagnostics (CRD)
CRD uses purified or recombinant individual allergen molecules rather than crude extracts to:
- Identify genuine sensitization vs. cross-reactivity
- Predict severity of reactions
- Guide immunotherapy decisions
| Marker | Clinical Significance |
|---|
| Ara h 2 (peanut 2S albumin) | Predicts severe peanut reactions |
| Ara h 8 (peanut PR-10) | Predicts mild OAS only (labile protein) |
| Bet v 1 (birch PR-10) | Primary sensitizer for PFAS — OAS only |
| Phl p 1 + 5 (grass) | Genuine grass sensitization → good candidate for AIT |
| Alt a 1 (Alternaria) | Severe asthma risk marker |
| Api m 1 vs. Ves v 5 | Differentiates bee vs. wasp genuine sensitization |
| Hev b 5, 6.01 (latex) | Confirms true latex allergy |
| nBet v 1 | PR-10 family — OAS risk |
10. Factors Influencing Allergenicity
Host Factors
- Genetics: HLA alleles, FcεRI polymorphisms, filaggrin (FLG) mutations (skin barrier defects → epicutaneous sensitization)
- Atopic predisposition: Family history
- Microbiome: Dysbiosis → reduced regulatory T cell induction
- Age at exposure: Early childhood exposure (oral tolerance) vs. sensitization window
- Route of exposure: Epicutaneous > airway > oral in terms of sensitization risk
Environmental Factors
- Hygiene hypothesis: Reduced microbial exposure in early life → Th2 bias (less Th1/Treg counter-regulation)
- Dose and duration: Both very low and very high chronic exposures may reduce sensitization; intermediate doses sensitize
- Pollution: Diesel exhaust particles act as adjuvants — enhance IgE responses, increase allergen penetration
- Climate change: Longer pollen seasons, higher pollen counts, altered mold distribution
- Adjuvants: LPS, proteases in allergen preparations influence sensitization magnitude
11. Specific Allergen Types in Detail
Superallergens
- Stimulate large fractions of T or B cells non-specifically
- Staphylococcal enterotoxins (SEB, SEA) — act as superantigens on T cells; amplify atopic dermatitis; induce polyclonal IgE production
- Protein A of S. aureus — cross-links IgE on mast cells via Fab variable regions
Pan-Allergens
Widely distributed proteins causing broad cross-reactivity:
- Profilins (Bet v 2): plant profilins → broad pollen and food cross-reactivity
- Polcalcins (Bet v 4, Phl p 7): calcium-binding proteins in pollen; cause multiple pollen sensitization
- nsLTPs (Pru p 3): found across plant kingdom; heat-stable; cause systemic food reactions
- Tropomyosin: invertebrate cross-reactivity (shellfish, dust mite, insects)
Recombinant vs. Natural Allergens
| Natural (n) | Recombinant (r) |
|---|
| Source | Purified from biological material | Produced in bacterial/yeast expression systems |
| Purity | Variable | High |
| Glycosylation | Present (CCD issues) | Often absent (unless mammalian expression) |
| Use | Diagnostics, some AIT | Research, CRD, next-gen AIT |
12. Routes of Allergen Challenge (Clinical)
| Route | Purpose | Example |
|---|
| Skin prick test (SPT) | Screening — detects sensitization | Standard 1st-line test |
| Intradermal test (IDT) | Higher sensitivity; drug/venom allergy | Second-line after negative SPT |
| Oral food challenge (OFC) | Gold standard for food allergy | Double-blind, placebo-controlled (DBPCFC) |
| Nasal provocation test | Confirm allergic rhinitis diagnosis | Rhinomanometry endpoint |
| Bronchial provocation test | Confirm allergen-induced asthma | FEV1 endpoint |
| Patch test | Type IV (contact allergy) | 48–96h reading |
| Basophil activation test (BAT) | In vitro; CD63/CD203c upregulation | Useful when SPT/OFC contraindicated |
13. Allergen Immunotherapy (AIT) — Allergen Perspective
Principle: Repeated administration of increasing doses of the causative allergen to induce immune tolerance.
| Form | Route | Key Notes |
|---|
| SCIT (Subcutaneous) | Subcutaneous injection | Standard; updosing + maintenance phases |
| SLIT (Sublingual) | Sublingual drops/tablets | Safer; HDM and grass tablets FDA-approved |
| OIT (Oral Immunotherapy) | Ingestion | Food allergy (peanut — Palforzia FDA-approved) |
| EPIT (Epicutaneous) | Skin patch | Peanut (Viaskin — investigational) |
Mechanisms of tolerance induction:
- Increase in regulatory T cells (Tregs) → IL-10, TGF-β
- Shift from IgE to IgG4 (blocking antibody)
- Mast cell and basophil hyporesponsiveness
- Dendritic cell tolerogenic phenotype shift
14. Measurement & Diagnosis of Allergen Sensitization
| Test | Principle | Notes |
|---|
| Serum specific IgE (sIgE) | ELISA/fluorescent enzyme immunoassay (ImmunoCAP) | Quantitative kU/L; not always correlates with clinical severity |
| Total IgE | Useful if very high (parasites, ABPA); low specificity for allergy alone | |
| Skin Prick Test | Allergen extract introduced into epidermis; wheal ≥3 mm = positive | Affected by antihistamines |
| Basophil Activation Test | CD63/CD203c flow cytometry | Useful for drugs, food, venom |
| CRD (ImmunoCAP ISAC) | Simultaneous testing of 112 allergen components on microarray | Broad sensitization profiling |
| Tryptase | Marker of mast cell activation; elevated in anaphylaxis | Elevated basally in mastocytosis |
15. Emerging Concepts
| Concept | Description |
|---|
| Epicutaneous sensitization | Broken skin barrier (FLG mutations in atopic dermatitis) allows allergen penetration → sensitization before oral exposure → explains sequence atopic dermatitis → food allergy ("atopic march") |
| Dual allergen exposure hypothesis | Early oral exposure → tolerance (LEAP trial); cutaneous exposure → sensitization |
| α-Gal syndrome | IgE to galactose-α-1,3-galactose (mammalian carbohydrate) induced by tick bites → delayed red meat allergy; Cetuximab reactions |
| MRGPRX2 | Non-IgE receptor on mast cells → pseudo-allergic reactions to drugs (opioids, muscle relaxants, fluoroquinolones) |
| Sensitization without allergy | >50% of sensitized individuals have no clinical symptoms — highlights role of threshold and tissue context |
| Climate change impact | Extended pollen seasons, geographic spread of new allergen sources (e.g., ragweed northward expansion in Europe) |
| Adjuvant-free AIT | Hypoallergens, peptide immunotherapy, tolerogenic nanoparticles under investigation |
Summary Mind Map (Key Relationships)
ALLERGEN
├── Properties: protein, 10–70 kDa, soluble, often proteolytic
├── Sources
│ ├── Aeroallergens: pollen, HDM, mold, animal dander, cockroach
│ ├── Food: Big 9, PR-10 (OAS), 2S albumins (systemic)
│ ├── Venoms: Hymenoptera
│ ├── Drugs: penicillin, NSAIDs, contrast
│ └── Occupational: latex, isocyanates, flour
├── Molecular families: prolamins, PR-10, profilins, lipocalins, tropomyosins
├── Cross-reactivity: birch-fruit, latex-fruit, shrimp-mite, α-gal
├── Sensitization pathway: alarmin → ILC2 → Th2 → IgE → mast cell priming
├── Diagnosis: SPT, sIgE, CRD, BAT, challenge tests
└── Treatment: AIT (SCIT, SLIT, OIT, EPIT) → Tregs, IgG4, tolerance
This covers the full scope of allergens as studied in allergology — from molecular biology and classification through clinical diagnostics and immunotherapy. Let me know if you want any section expanded further (e.g., specific allergen families, CRD interpretation, AIT protocols).